José Baselga and Jean-Luc Butel join Varian Medical Systems board
Dr. Baselga has served as Physician-in-Chief at MSK and Professor of Medicine at Weill Cornell Medical College since 2013.
Prior to MSK, Dr. Baselga was the Chief of the Division of Hematology / Oncology, Associate Director of the Massachusetts General Hospital Cancer Center and Professor of Medicine at Harvard Medical School from 2010-2012.
Dr. Baselga was also the Chairman of Medical Oncology and Founding Director of the Vall d'Hebron Institute of Oncology in Barcelona, Spain from 1996-2010.
Dr. Baselga received his medical degree from Universitat Autonoma de Barcelona in Barcelona, Spain and completed residencies at Vall d'Hebron University Hospital and State University of New York Health Science Center at Brooklyn.
Dr. Baselga is the most recent Past President of the American Association of Cancer Research and an elected member of the National Academy of Medicine. Dr. Baselga is a member of the Board of Directors of Infinity Pharmaceuticals.
Mr. Butel has served as Senior Adviser to McKinsey Healthcare Practice since 2015.
From 2012 to 2015, Mr. Butel served as Corporate Vice President and President of International at Baxter. He has held prior executive management positions at Medtronic, Johnson & Johnson, and Becton-Dickinson.
Mr. Butel earned a BA in International Affairs from The George Washington University and a MBA in international management from the American Graduate School of International Management (Thunderbird).
Mr. Butel is a member of the Board of Directors of the Singapore Economic Development Board and Takeda Pharmaceutical Company. ■
LATEST MOVES FROM California
- Reed's appoints Stefan Freeman as interim CEO
- Heron Therapeutics appoints Robert E. Hoffman as CFO
- Penumbra appoints Bridget O'Rourke to board
- Adverum Biotechnologies adds Richard N. Spivey to board
- Lombard Medical appoints Kurt Lemvigh as CEO
More inside POST
UK inflation steady in March Economy